Hochschulschrift
Detektion der BCR/ABL1-Fusion – Vergleichende Analyse sechs kommerzieller Sondensätze für die Fluoreszenz-in-situ-Hybridisierung
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Ulm, Universität Ulm, Dissertation, 2017
- Keyword
-
Zellfusion
Fluoreszenz-in-situ-Hybridisierung
Chromosom
Leukämie
DNS
Myelose
Patient
Chronisch-myeloische Leukämie
Chromosomenaberration
Molekulargenetik
Fluoreszenz-in-situ-Hybridisierung
Krebs
Onkologie
- DOI
-
10.18725/OPARU-4485
- URN
-
urn:nbn:de:bsz:289-oparu-4524-4
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Knas, Tanja
- Universität Ulm
Time of origin
- 2017
Other Objects (12)
Genomische BCR-ABL1-Bruchpunkte bei kindlichen Leukämien
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy
Multiphotonen-Multicolor-Fluoreszenz in situ Hybridisierung
Multiphotonen-Multicolor-Fluoreszenz in situ Hybridisierung
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K
Comparative genomische Hybridisierung und Fluoreszenz-in-situ- Hybridisierung beim multiplen Myelom
Comparative genomische Hybridisierung und Fluoreszenz-in-situ- Hybridisierung beim multiplen Myelom
Genomische BCR-ABL1-Bruchpunkte bei kindlichen Leukämien
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy
Multiphotonen-Multicolor-Fluoreszenz in situ Hybridisierung
Multiphotonen-Multicolor-Fluoreszenz in situ Hybridisierung
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K
Comparative genomische Hybridisierung und Fluoreszenz-in-situ- Hybridisierung beim multiplen Myelom
Comparative genomische Hybridisierung und Fluoreszenz-in-situ- Hybridisierung beim multiplen Myelom
Genomische BCR-ABL1-Bruchpunkte bei kindlichen Leukämien
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy
Multiphotonen-Multicolor-Fluoreszenz in situ Hybridisierung
Multiphotonen-Multicolor-Fluoreszenz in situ Hybridisierung
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K
Comparative genomische Hybridisierung und Fluoreszenz-in-situ- Hybridisierung beim multiplen Myelom